Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
QuintilesIMS
Argus Health
AstraZeneca
Express Scripts
Teva
Moodys
Healthtrust
Dow

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GRALISE

« Back to Dashboard

Clinical Trials for Gralise

Trial ID Title Status Sponsor Phase Summary
NCT01301001 A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response Completed University of Tennessee Health Science Center N/A The Specific aims of this project are to (1) test the prediction that pain from tampon insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin compared to when treated with placebo. Secondary outcome measures include intercourse pain and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more specific treatment options.
NCT01301001 A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response Completed University of Tennessee N/A The Specific aims of this project are to (1) test the prediction that pain from tampon insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin compared to when treated with placebo. Secondary outcome measures include intercourse pain and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more specific treatment options.
NCT01623271 Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise) Terminated Massachusetts General Hospital N/A The purpose of this study is to see if an FDA-approved drug (Gralise) can help people with certain types of neuropathic pain without causing too many side effects.
NCT01678911 Efficacy of Gralise® for Chronic Pelvic Pain Terminated Rehabilitation Institute of Chicago Phase 4 This study is done to investigate the pain relieving effects of the study drug Gralise (a novel long acting gabapentinoid) for people who experience chronic pelvic pain. Subjects with Irritable Bowel Syndrome, Interstitial Cystitis, Ulcerative Colitis, and Prostatitis will be recruited. The purpose of this research is to look at how the study drug can be used to benefit people who experience this type of pain. This is a phase IV study done to study the safety and effectiveness of the drug. At this point the drug has been approved by the Food and Drug Administration and has been reported to be well tolerated and effective in the treatment of various chronic pain conditions, particularly in neuropathic pain. About 36 subjects will take part in this study.
NCT01764464 GRASSP: Gralise® for Spine Surgery Pain Recruiting University of Rochester Phase 4 Evaluate the analgesic benefit of Gralise® for post-laminectomy pain syndrome (PLPS)
NCT01776671 Once Daily Gabapentin in the Treatment of Post Amputation Pain Recruiting Chicago Anesthesia Pain Specialists Phase 3 Phantom limb pain (PLP) is a common disorder reported by the patients who undergo amputation. Even though the cause of PLP remains unclear, Gabapentin has been widely used. The purpose of this study is to evaluate the accuracy and efficacy achieved in using of extended release Gabapentin. Reducing the incidence of chronic post-amputation pain and improving clinical outcomes postoperatively.
NCT02052414 Study of Gralise to Treat Fibromyalgia Patients Completed Depomed N/A To determine Gralise in treating fibromyalgia pain: - efficacy - safety
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Gralise

Condition Name

Condition Name for Gralise
Intervention Trials
Ulcerative Colitis 1
Complex Regional Pain Syndrome I (CRPS I) 1
Pain 1
Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Gralise
Intervention Trials
Head and Neck Neoplasms 2
Syndrome 2
Somatoform Disorders 2
Complex Regional Pain Syndromes 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Gralise

Trials by Country

Trials by Country for Gralise
Location Trials
United States 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Gralise
Location Trials
New York 3
Illinois 2
North Carolina 1
Massachusetts 1
Tennessee 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Gralise

Clinical Trial Phase

Clinical Trial Phase for Gralise
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
N/A 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Gralise
Clinical Trial Phase Trials
Completed 3
Recruiting 3
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Gralise

Sponsor Name

Sponsor Name for Gralise
Sponsor Trials
Depomed 2
University of Tennessee 1
The Center for Clinical Research, Winston-Salem, NC 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Gralise
Sponsor Trials
Other 9
Industry 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Merck
Johnson and Johnson
Daiichi Sankyo
Healthtrust
McKesson
QuintilesIMS
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.